DoD Kidney Cancer, Clinical Trial Award
ID: 355340Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355340
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Kidney Cancer Research Program (KCRP) Clinical Trial Award, aimed at advancing innovative clinical trials that significantly impact kidney cancer treatment and management. This grant supports a range of clinical trials, from pilot studies to large-scale projects, requiring preliminary data, access to suitable patient populations, and robust statistical analysis plans. With an estimated total program funding of $6.4 million, the program anticipates awarding approximately two grants, with applications due by October 15, 2024, following a Letter of Intent submission by September 24, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524KCRPCTA_GG.pdf
    The DOD FY24 Kidney Cancer Clinical Trial Award is part of the Defense Health Program's Congressionally Directed Medical Research Programs aimed at advancing kidney cancer research. This grant seeks applications for rigorous, innovative clinical trials addressing kidney cancer, with a budget of $50 million for FY24. Key submission dates include the Letter of Intent due by September 24, 2024, and full applications by October 15, 2024. The program emphasizes understanding kidney cancer biology, developing new therapeutic strategies, improving patient care, and addressing health disparities, particularly for active duty military and veterans. Eligible applicants include organizations both within and outside the Department of Defense, while the funding initiative supports trials from pilot studies to larger-scale projects. The application process consists of a two-step submission, requiring a pre-application followed by a full application, with specific expectations for preliminary data, patient population access, and statistical analysis plans. This initiative is designed to catalyze impactful kidney cancer research that aligns with the strategic goals of the Kidney Cancer Research Program, ensuring that new discoveries translate into improved clinical outcomes for patients.
    Similar Opportunities
    NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22), aimed at supporting senior postdoctoral fellows in their transition to independent research roles. This grant specifically targets candidates from diverse backgrounds, with the objective of fostering an inclusive research workforce and enhancing cancer research capabilities. The K22 award provides three years of salary and research funding, encouraging the development of independent research projects, particularly those leading to clinical trials. Interested applicants must adhere to NIH guidelines and submit their applications by January 7, 2028, with further details available at NIH Grants. For inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08), aimed at fostering diversity within the cancer research workforce. This grant supports clinical scientists with doctoral degrees who are underrepresented in health-related research, providing salary support for a 3-5 year period to gain intensive research training in various cancer research fields, particularly focusing on health disparities. The program is designed to enhance the research capabilities of awardees, preparing them for independent research careers in basic biomedical, behavioral, or translational cancer research. Interested applicants should note that the application period opens on January 12, 2025, with a submission deadline of February 12, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-320.html.
    Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Institutional Network Award (U2C) to enhance training in kidney, urologic, and hematologic research. This funding opportunity aims to foster a collaborative environment by inviting institutions to submit a unified application that supports a cohort of trainees and early-career investigators, with a strong emphasis on partnerships among institutions within metropolitan areas. The initiative is crucial for reshaping research training and promoting scientific collaboration, ensuring that the next generation of researchers is equipped to address complex biomedical challenges. Applications will be accepted starting October 16, 2023, with a submission deadline of September 27, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Innovative Approaches for Reducing Disparities in Kidney Health
    Active
    Office of the Assistant Secretary for Health
    The Office of the Assistant Secretary for Health is forecasting a federal grant opportunity titled "Innovative Approaches for Reducing Disparities in Kidney Health" aimed at addressing chronic kidney disease (CKD) disparities through community-based strategies. This grant will support demonstration projects that adapt evidence-based approaches to reduce CKD and its related risk factors, particularly focusing on groups disproportionately affected by these health issues. With an estimated total program funding of $2 million, the agency anticipates awarding four grants, each ranging from $425,000 to $500,000, with applications due by February 11, 2025. Interested applicants can reach out to Alana Sutherland at OMHGrants@hhs.gov or by phone at 301-945-3668 for further information.
    Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)." This initiative aims to support the development of innovative tools and technologies that address significant challenges in kidney, urologic, and hematologic research, encouraging high-risk, exploratory projects that differ from traditional R01 grants. The funding, with a maximum budget of $275,000 over two years, is open to a diverse range of eligible applicants, including various educational institutions and community organizations, with applications due by January 7, 2025. For further details, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-23-119.html.
    NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Mentored Clinical Scientist Research Career Development Award (K08), aimed at enhancing diversity within the cancer research workforce. This grant supports individuals from underrepresented backgrounds with clinical doctoral degrees, providing them with an intensive, mentored research experience over a period of 3-5 years, focused on biomedical, behavioral, and translational cancer research. The program is critical for developing the skills necessary to lead independent clinical trials and to prepare awardees for competitive research project grants, addressing significant health disparities in cancer research. Interested applicants must submit their proposals by January 7, 2025, and can find additional information at NIH Grants. For inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22), aimed at supporting diverse candidates transitioning from postdoctoral roles to independent research positions in cancer research. This grant provides financial support for up to three years, covering salary and research costs, specifically targeting senior postdoctoral fellows and individuals in equivalent positions who have completed relevant training and hold early-stage investigator status. The initiative emphasizes the importance of diversity in the biomedical workforce, encouraging applications from underrepresented groups, while stipulating that candidates cannot lead their own clinical trials but may participate in trials led by mentors. Interested applicants should note that the application deadline is January 7, 2028, and can find further details and guidelines in the full announcement available at NIH Grants. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12), aimed at supporting newly trained clinicians committed to independent research careers in community oncology and cancer prevention. This grant opportunity encourages the development of community-based clinical trials and ancillary studies, with a strong emphasis on addressing health disparities and improving access to cancer clinical trials for underserved populations. Eligible applicants include a diverse range of organizations, particularly those serving underrepresented groups, with funding available for up to five years to support program planning and mentorship. Interested parties can find more information and application details at the NIH grants website, with the application deadline set for February 18, 2027.
    Notice of Intent to Publish a Funding Opportunity Announcement for Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the Paul Calabresi Career Development Award for Clinical Oncology (K12), aimed at supporting institutional research career development programs for clinical scientists in cancer research. This initiative emphasizes training for clinical scientists who aspire to lead independent clinical trials or contribute to existing trials, thereby enhancing the field of clinical cancer research. The NOFO is anticipated to be released in November 2024, with the first application deadline set for February 2025, and the estimated award date is January 5, 2026. Interested applicants are encouraged to begin developing collaborations and applications in advance, as there are no cost-sharing requirements associated with this grant opportunity.
    Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced a funding opportunity titled "Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)." This initiative aims to support exploratory research projects that focus on the early-stage development of innovative technologies for molecular and cellular analysis in cancer research, with an emphasis on enhancing characterization of cancer biology and addressing health disparities. Eligible applicants include a wide range of organizations, such as higher education institutions, non-profits, and tribal governments, with funding available up to $150,000 annually for a project period not exceeding three years. The total estimated funding for this program is approximately $4.2 million, with about 17 awards expected to be made. Interested applicants can find more information and submit inquiries via email to grantsinfo@nih.gov, with applications due by October 3, 2025.